Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-24-050401·Commodore Capital LP
Schedule 13G ownership disclosure
Cardiff Oncology Inc
Common Stock, $0.0001 par value · CUSIP: 14147L108
Event date: 2024-12-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- COMMODORE CAPITAL LP
Shares: 5,384,616.00 · Class: 8.1%
- Commodore Capital Master LP
Shares: 5,384,616.00 · Class: 8.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-050401
- Form type
- SCHEDULE 13G
- Filer
- Commodore Capital LP
- CIK
- CIK 1831942
- Filed
- Dec 17, 2024
- Reporting period
- Dec 10, 2024
- Description
- Schedule 13G beneficial ownership